Matthew Frankel

Matthew Frankel

No open positions remaining
58 year
Health Technology
Consumer Services

Profile

Matthew B. Frankel formerly worked at Reata Pharmaceuticals, Inc., as Global Medical Director from 2010 to 2012, Boehringer Ingelheim Pharmaceuticals, Inc., as VP-Clinical Development & Medical Affairs from 2018 to 2022, Novartis Pharmaceuticals Corp., as VP, Head-Immunology & Dermatology from 2016 to 2018, and Chemomab Therapeutics Ltd., as Chief Medical Officer & VP-Drug Development from 2022 to 2025.
Dr. Frankel received his undergraduate degree from Vassar College, doctorate degree from David Geffen School of Medicine, and Masters Business Admin degree from Kellogg School of Management.

Former positions of Matthew Frankel

CompaniesPositionEnd
CHEMOMAB THERAPEUTICS LTD. Chief Tech/Sci/R&D Officer 15/04/2025
Chief Tech/Sci/R&D Officer 01/11/2022
Corporate Officer/Principal 01/01/2018
REATA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/01/2012
See the detail of Matthew Frankel's experience

Training of Matthew Frankel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

17

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Matthew Frankel
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!